Track the news on our web site as we have almost started the countdown to the very first public release of our workflow system "From genome to target" for automatized search of new therapeutic targets.
Come and join us on the grand opening of Biosoft's new office in Skolkovo Technopark on April 21st! You will find interesting lectures on bioinformatics, workshops and a hakaton on search for personalized biomarkers and drug targets on real patient's data.
Join us on April 13th if you are interested in molecular medicine and drug development, as we are going to give a webinar on the basic approach for searching for new drug targets and biomarkers.
Biosoft's project on development of prognostic biomarkers for colorectal cancer had got a second place on the omics 2015 competition and was awarded with a 5 000 000 rub. certificate from the Skolkovo Foundation.
The Biosoft project was presented at the StartUp Village 2014 conference, where in the scope of InBioMed competition it was honored with the rank of one of the most attractive investment projects in the biomedical technologies sphere.
Biosoft gets a BB index form the Russian Startup Index (RSI) rating agency
A paper about our new tool – cutPrimers was published in Journal of Computational Biology. The tool allows to accurately cut primers from reads of targeted next generation sequencing without coverage reduction.
An article, showing the abilities of the developed by LLC "BIOSOFT.RU" workflow system "From genome to target" in application for lung cancer, was published in Virtual Biology journal: "Master-regulators driving resistance of non-small cell lung cancer cells to p53 reactivator Nutlin-3".
In Nucleic Acids Research journal a new publication about the developed by LLC "BIOSOFT.RU" database on transcription factor binding sites has been published: "GTRD: a database of transcription factor binding sites identified by ChIP-seq experiments".